Dianthus Therapeutics | MGTA - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Akebia Therapeutics USD 160.86M 13.02M 2026-06
Alaunos Therapeutics USD 595K 218K 2026-03
Avita Medical AUD 62.68M 77K 2025-12
Celltrion KRW 292.71B 9.09B 2026-03
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 34.39M 3.89M 2026-06
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
IQVIA Holdings USD 8.82B 486M 2026-06
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Moderna USD 2.53B 139M 2026-06
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 88.74M 5.31M 2026-03
Organon & Co USD 2.62B 116M 2026-06
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pharma Mar EUR 98.42M 9.2M 2026-06
Qiagen NV USD 581.45M 102.34M 2026-06
Revvity USD 1.28B 37.71M 2026-06
Sartorius EUR 1.44B 668.7M 2026-06
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tectonic Therapeutic USD 12.96M 3.29M 2026-03
Tilray USD 259.32M 8.32M 2025-09
Viatris USD 6.35B 464.5M 2026-06
Xeris Pharmaceuticals USD 189.57M 70.97M 2026-06
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 3.02B 742.54M 2026-06